Society Of Urologic Oncology Clinical Trials Consortium
| Fiscal year | Revenue | Expenses | Net | Reserve mo. | Staff % |
|---|---|---|---|---|---|
| 2012 | 166,273 | 148,950 | 17,323 | 0.3 | — |
| 2013 | 226,411 | 128,372 | 98,039 | 9.6 | 0% |
| 2014 | 164,015 | 134,843 | 29,172 | 11.7 | — |
| 2015 | 163,344 | 155,847 | 7,497 | 10.7 | — |
| 2016 | 123,900 | 148,236 | −24,336 | 9.3 | — |
| 2017 | 224,904 | 162,873 | 62,031 | 13.0 | 0% |
| 2018 | 291,975 | 147,738 | 144,237 | 26.1 | 0% |
| 2019 | 258,725 | 160,007 | 98,718 | 31.5 | 0% |
| 2020 | 213,800 | 163,220 | 50,580 | 34.6 | 0% |
| 2021 | 219,505 | 154,114 | 65,391 | 41.7 | 0% |
| 2022 | 626,645 | 183,608 | 443,037 | 64.0 | 0% |
| 2023 | 332,300 | 237,946 | 94,354 | 54.1 | 0% |
In its most recent public year (2023), this organization brought in $94,354 more than it spent. Its reserves stood at about 54.1 months of spending, up from 0.3 in 2012. Staff pay was 0% of spending.
Reserve months = net assets ÷ average monthly spending; net assets count everything the organization owns beyond its debts — buildings and donor-restricted funds included, not just cash. Staff pay = salaries, wages, and officer compensation; it excludes benefits and payroll taxes. The IRS releases this data years after the fact — this organization's newest public year is 2023. Years refer to the calendar year in which the organization's fiscal year ended. Short-form filers do not publicly report donor-restricted balances or staffing costs. Source filings
Society Of Urologic Oncology Clinical Trials Consortium's IRS filings as a feed — one entry per filing year, through 2023. Add the address to any feed reader; in Slack, send /feed subscribe with it (pasting the link alone won't subscribe). How this feed works